Lung Cancer in Mexico: Perspectives from the North and Ciudad de Mexico
En este episodio de Lung Cancer Considered, vamos a hablar sobre el cancer de pulmón en México. Tengo el placer de tener en este episodio dos doctores con mucha experiencia tratando y entendiendo las...
27 Jan 202547min
IASLC Lung Cancer Considered in German
Description: As part of IASLC’s commitment to communicating in all world languages, this episode of Lung Cancer Considered is recorded in German and is part of our Virtual Tumor Board series. Host Pr...
22 Jan 202552min
FDA Approval Zenocutuzumab For NRG1 Fusion Cancers
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of zenocutuzumab for NSCLC with an NRG1 fusion. NRG1 fusions are rare but important events seen in ma...
21 Jan 202520min
ESMO Immuno-Oncology Congress 2024 Highlights
ESMO Immuno-Oncology Congress 2024 Highlights Description: In this episode of Lung Cancer Considered, host Dr. Narjust Florez and Dr. Alfredo Addeo discuss some of the data presented at The ESMO Im...
13 Jan 202545min
2025 Pan-Africa Conference on Lung Cancer Meeting Preview
Preview: 2025 Pan-Africa Lung Cancer Meeting The 2025 Pan-Africa Lung Cancer Conference will take place January 31 - February 1, 2025, in Accra, Ghana and represents the first IASLC multidisciplinary...
18 Des 202446min
IASLC Lung Cancer Considered: ESMO Asia 2024 Highlights
Lung Cancer Considered host Dr. Stephen Liu and two distinguished thoracic oncologists review the highlights from the recently completed ESMO Asia 2024 meeting, held in Singapore. The episode covers ...
16 Des 202432min
FDA Approval: TT Fields for NSCLC
Tumor Treating Fields (TTFields) is a non-invasive cancer treatment that uses alternating electric fields to disrupt the ability of cancer cells to divide. TTFields can slow down tumor growth and spre...
13 Des 202437min
FDA Approval: Perioperative Nivolumab + Chemotherapy - CheckMate 77T
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the FDA approval of perioperative nivolumab based on the Phase III CheckMate 77T study. Perioperative therapy has ...
12 Des 202448min
